[india today] India is in the process of supplying anti-malarial drug hydroxychloroquine to 55 coronavirus-hit countries as grants as well as on commercial basis, sources said.
In order to help other countries fight the pandemic, India has prepared a set of three lists of countries that would receive supplies of Hydroxychloroquine, an anti-malarial drug.
The list of countries to which India is supplying Hydroxychloroquine is Afghanistan, Bhutan, Bangladesh, Nepal, Maldives, Mauritius, Seychelles, Sri Lanka, Dominican Republic, Madagascar, Myanmar, Zambia, Uganda, Burkina Faso, Niger, Mali, Democratic Republic of Congo, Egypt, Armenia, Kazakhstan, Ecuador, Jamaica, Marshall Islands, Syria, Ukraine, Eswatini, Chad, Republic of Congo, Senegal, Sierra Leone, Zimbabwe, France, Jordan, Kenya, Netherlands, Nigeria, Oman, Peru, Philippines, Russia, Slovenia, South Africa, Tanzania, UAE, Uzbekistan, Uruguay, Colombia, Algeria, Bahamas, Bolivia, Guyana, UK, US.
| Oooohhh, that’s us at the very end of the list! |
“As part of these efforts, Rapid Antibody Testing Kits (first lot of 3 lakh from Guangzhou Wondfo and 2.5 lakh from Zhuhai Livzon) and RNA Extraction Kits (1 lakh from MGI Shenzhen), all custom cleared yesterday late night have left this morning for India. In total, 6.5 lakh kits are on the way; should reach today (Thursday). Our Embassy in Beijing and Consulate in Guangzhou played a key role," a source said.
Sources told India Today that more testing kits are on also their way from South Korea. “We have also received quotations from UK, France, Canada, US, Malaysia, Germany and Japan," the source said.
Sources, however, said that PPEs would not be procured from China even as testing kits are being imported. There have been reports of many of the PPEs being found "faulty" and "sub-standard".
Another source, without naming which country the consignment is coming, said “a large consignment of PPE was arriving in India. It could be similar to the number of testing kits”.
|
